Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

611 - 620 of 805 results found

Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine

Date
Wednesday, May 17, 2023 - 4:00 AM
Description
CONCLUSION: Guillain-Barré syndrome after COVID-19 vaccination is responsive to treatment. The benefits of administering the vaccine outweigh the risks. Due to the negative impact of COVID-19, it is essential to recognize the development of